• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏耐受的细胞和分子机制。

Cellular and molecular mechanisms of liver tolerance.

作者信息

Crispe Ian N, Giannandrea Matthew, Klein Ingo, John Beena, Sampson Bradford, Wuensch Sherry

机构信息

The Liver Immunobiology Program, David H Smith Center for Vaccine Biology and Immunology, The University of Rochester, Rochester, NY 14642, USA.

出版信息

Immunol Rev. 2006 Oct;213:101-18. doi: 10.1111/j.1600-065X.2006.00435.x.

DOI:10.1111/j.1600-065X.2006.00435.x
PMID:16972899
Abstract

The liver exhibits a distinctive form of immune privilege, termed liver tolerance, in which orthotopic liver transplantation results in systemic donor-specific T-cell tolerance, while antigens introduced either into hepatocytes or via the portal vein also cause tolerance. Here we argue that the fundamental mechanism driving liver tolerance is likely to be the continuous exposure of diverse liver cell types to endotoxin, derived from the intestinal bacteria. This exposure promotes the expression of a set of cytokines, antigen-presenting molecules, and costimulatory signals that impose T-cell inactivation, partly via effects on liver antigen-presenting cells. The evidence favors clonal deletion mechanisms and is consistent with a role for regulatory T cells but does not support either anergy or immune deviation as important factors in liver tolerance.

摘要

肝脏表现出一种独特的免疫赦免形式,称为肝脏耐受性,其中原位肝移植会导致全身性供体特异性T细胞耐受,而引入肝细胞或通过门静脉引入的抗原也会引发耐受。我们认为,驱动肝脏耐受性的基本机制可能是多种肝细胞类型持续暴露于源自肠道细菌的内毒素。这种暴露促进了一组细胞因子、抗原呈递分子和共刺激信号的表达,这些信号部分通过对肝脏抗原呈递细胞的作用使T细胞失活。证据支持克隆清除机制,与调节性T细胞的作用一致,但不支持无反应性或免疫偏离是肝脏耐受性的重要因素。

相似文献

1
Cellular and molecular mechanisms of liver tolerance.肝脏耐受的细胞和分子机制。
Immunol Rev. 2006 Oct;213:101-18. doi: 10.1111/j.1600-065X.2006.00435.x.
2
Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.免疫豁免、T细胞耐受性和组织限制性自身免疫
Hum Immunol. 1997 Feb;52(2):138-43. doi: 10.1016/S0198-8859(96)00288-1.
3
Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell.肝窦内皮细胞:一种新型的器官驻留抗原呈递细胞。
Arch Immunol Ther Exp (Warsz). 2001;49 Suppl 1:S7-11.
4
Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.吲哚胺2,3-双加氧酶在大鼠肝脏同种异体移植排斥反应和耐受中的免疫作用
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e243-50. doi: 10.1111/j.1440-1746.2007.05036.x. Epub 2007 Jul 23.
5
Mechanisms balancing tolerance and immunity in the liver.肝脏中平衡耐受和免疫的机制。
Dig Dis. 2011;29(4):384-90. doi: 10.1159/000329801. Epub 2011 Aug 30.
6
Toward tolerance: lessons learned from liver transplantation.走向耐受性:肝移植的经验教训。
Liver Transpl Surg. 1999 Jul;5(4 Suppl 1):S90-7. doi: 10.1053/JTLS005s00090.
7
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.
8
The liver mediates apoptotic cell-induced immune regulation.
Scand J Immunol. 2008 Sep;68(3):297-305. doi: 10.1111/j.1365-3083.2008.02141.x.
9
Liver immunobiology.肝脏免疫生物学
Toxicol Pathol. 2005;33(1):52-62. doi: 10.1080/01926230590522365.
10
Taking off the brakes: T cell immunity in the liver.解除刹车:肝脏中的 T 细胞免疫。
Trends Immunol. 2010 Aug;31(8):311-7. doi: 10.1016/j.it.2010.06.001. Epub 2010 Jul 9.

引用本文的文献

1
Human liver derived mesenchymal stromal cells ameliorate murine ischemia-induced inflammation through macrophage polarization.人源肝来源间充质基质细胞通过巨噬细胞极化改善小鼠缺血性炎症。
Front Immunol. 2024 Jul 22;15:1448092. doi: 10.3389/fimmu.2024.1448092. eCollection 2024.
2
Leukocyte immunoglobulin-like receptor B4 (LILRB4) in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target.急性髓系白血病中的白细胞免疫球蛋白样受体B4(LILRB4):从预后生物标志物到免疫治疗靶点
Chin Med J (Engl). 2024 Nov 20;137(22):2697-2711. doi: 10.1097/CM9.0000000000003195. Epub 2024 Jul 8.
3
infection in juvenile pigs elicits a local Th2 response in a setting of ongoing Th1 expansion.
在持续 Th1 扩增的背景下,幼年猪感染会引发局部 Th2 反应。
Front Immunol. 2024 May 10;15:1396446. doi: 10.3389/fimmu.2024.1396446. eCollection 2024.
4
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future.肝细胞癌免疫治疗的治疗选择:现状与未来。
J Clin Transl Hepatol. 2024 Apr 28;12(4):389-405. doi: 10.14218/JCTH.2023.00462. Epub 2024 Feb 28.
5
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target.肠道微生物群在癌症免疫治疗中的作用:从预测生物标志物到治疗靶点。
Exp Hematol Oncol. 2023 Sep 28;12(1):84. doi: 10.1186/s40164-023-00442-x.
6
Cell transplantation-based regenerative medicine in liver diseases.基于细胞移植的肝脏疾病再生医学。
Stem Cell Reports. 2023 Aug 8;18(8):1555-1572. doi: 10.1016/j.stemcr.2023.06.005.
7
Prognostic model of immune-related genes for patients with hepatocellular carcinoma.肝细胞癌患者免疫相关基因的预后模型
Front Surg. 2022 Jul 21;9:819491. doi: 10.3389/fsurg.2022.819491. eCollection 2022.
8
Innovations in Immunosuppression for Intestinal Transplantation.肠道移植免疫抑制的创新
Front Nutr. 2022 Jun 15;9:869399. doi: 10.3389/fnut.2022.869399. eCollection 2022.
9
The current state of knowledge of the immune ecosystem in alopecia areata.斑秃免疫生态系统的当前知识状态。
Autoimmun Rev. 2022 May;21(5):103061. doi: 10.1016/j.autrev.2022.103061. Epub 2022 Feb 10.
10
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.非酒精性脂肪性肝病中的炎症与纤维化:肝脏免疫系统的作用
Front Med (Lausanne). 2021 Dec 9;8:781567. doi: 10.3389/fmed.2021.781567. eCollection 2021.